Johnson & Johnson (JNJ) Settles Risperdal Side Effect Lawsuit
9/11/2012 7:12:09 AM
With a Philadelphia jury waiting - and the company wanting to avoid having the judge order chief executive officer Alex Gorsky to testify - health care giant Johnson & Johnson Monday settled a lawsuit brought by a man who said its antipsychotic drug Risperdal had caused him to grow breasts. The trial, one of hundreds involving allegations of inappropriate marketing of the drug, was set to begin in Philadelphia Common Pleas Court before Judge George W. Overton. The only remaining pretrial motion was a defense request to quash a subpoena to compel testimony from Gorsky, who led Janssen, the J&J subsidiary that made Risperdal during the period when the man was taking the drug.